Literature DB >> 10851390

Lambert-Eaton myasthenic syndrome: electrodiagnostic findings and response to treatment.

R W Tim1, J M Massey, D B Sanders.   

Abstract

The authors reviewed the incidence of cancer, repetitive nerve stimulation findings, and response to treatment in 73 patients with Lambert-Eaton myasthenic syndrome. Thirty-one patients (42%) had lung cancer, 29 small cell. Doubling of the compound motor action potential amplitude in three tested distal muscles was seen in only 41% of patients. Treatment with 3, 4-diaminopyridine produced moderate to marked self-reported functional improvement in 79% of the 53 treated patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10851390     DOI: 10.1212/wnl.54.11.2176

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  Progress in the management of paraneoplastic neurological disorders.

Authors:  Hamid Sadeghian; Steven Vernino
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

2.  Associated autoimmune diseases in patients with the Lambert-Eaton myasthenic syndrome and their families.

Authors:  Paul W Wirtz; Jennifer Bradshaw; Axel R Wintzen; Jan J Verschuuren
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

3.  Autonomic dysfunction in Lambert-Eaton myasthenic syndrome.

Authors:  S A Waterman
Journal:  Clin Auton Res       Date:  2001-06       Impact factor: 4.435

Review 4.  Neurologic paraneoplastic syndromes.

Authors:  Edward J Dropcho
Journal:  Curr Oncol Rep       Date:  2004-01       Impact factor: 5.075

Review 5.  The therapy of congenital myasthenic syndromes.

Authors:  Andrew G Engel
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

Review 6.  Synaptic Pathophysiology and Treatment of Lambert-Eaton Myasthenic Syndrome.

Authors:  Tyler B Tarr; Peter Wipf; Stephen D Meriney
Journal:  Mol Neurobiol       Date:  2014-09-09       Impact factor: 5.590

7.  Autoimmune channelopathies of the nervous system.

Authors:  Kleopas A Kleopa
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

8.  Autoimmune neuromuscular disorders.

Authors:  Jessica Kraker; Saša A Zivković
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

9.  Hypotension due to Chemotherapy in a Patient with Small Cell Lung Cancer and Lambert-Eaton Myasthenic Syndrome Undergoing Hemodialysis: A First Case Report.

Authors:  Taiji Kuwata; Hidetaka Uramoto; Tetsuro Baba; Fumihiro Tanaka
Journal:  Case Rep Oncol       Date:  2012-01-25

10.  A case of Lambert-Eaton myasthenic syndrome associated with atypical bronchopulmonary carcinoid tumor.

Authors:  Jae-Hyeok Lee; Jin-Hong Shin; Dae-Seong Kim; Dae Soo Jung; Kyu-Hyun Park; Min-Ki Lee; Jee-Yeon Kim
Journal:  J Korean Med Sci       Date:  2004-10       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.